← Back to Search

Observational (HRV monitoring, questionnaire) for Pancreatic Cancer

N/A
Waitlist Available
Led By Aaron Grossberg
Research Sponsored by OHSU Knight Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years post enrollment
Awards & highlights
No Placebo-Only Group

Summary

This trial is looking at whether heart rate variability can help detect pancreatic cancer earlier. Pancreatic cancer is difficult to detect early, so this could be useful.

Eligible Conditions
  • Pancreatic Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years post enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years post enrollment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Compliance statistics for wristband use (Stage II)
Magnitude of heart rate variability (HRV) decline (Stage I)
Secondary study objectives
Compliance statistics for wristband use for all participants (Stage I, II)
Effectiveness of virtual training (Stage I, II)
Magnitude of HRV change (Stage II)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Observational (HRV monitoring, questionnaire)Experimental Treatment3 Interventions
Participants undergo HRV monitoring using an activity monitor (WHOOP) for a minimum of 5 days weekly for up to 1 year in patients with newly-diagnosed PDAC and up to 5 years for patients in high risk group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Activity Monitor
2013
N/A
~320

Find a Location

Who is running the clinical trial?

OHSU Knight Cancer InstituteLead Sponsor
235 Previous Clinical Trials
2,088,533 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,887 Previous Clinical Trials
41,020,918 Total Patients Enrolled
American Association for Cancer ResearchOTHER
8 Previous Clinical Trials
722 Total Patients Enrolled
~22 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top